Morgan Stanley Direct Lending Fund — Form 8-K Summary
Business Context and Reporting Period
The company filed a Form 8-K dated July 22, 2021, reporting events occurring on July 6 and July 16, 2021. The filing concerns a new secured revolving credit facility and an equity capital drawdown. The company has no securities registered under Section 12(b) of the Exchange Act.
Key Financial and Capital Structure Matters
- Revolving credit facility: On July 16, 2021, the company entered into a senior secured revolving credit agreement with Truist Bank as administrative agent.
- Commitment: Maximum principal amount of $650 million, subject to borrowing-base availability, with an uncommitted accordion feature permitting capacity to increase to $1.0 billion if lenders agree.
- Other facility limits: The facility includes a $50 million swingline sublimit and a $50 million letter-of-credit sublimit.
- Collateral and guarantees: The facility is guaranteed by certain domestic subsidiaries and secured by a perfected first-priority interest in substantially all assets of the company and guarantors, subject to specified exceptions.
- Term: The availability period ends July 16, 2025, and the facility matures July 16, 2026, absent an event of default.
- Pricing: Borrowings bear interest based on either an alternate base rate plus a spread of 0.75% or 0.875%, or the applicable LIBO Rate plus a spread of 1.75% or 1.875%, depending on borrowing-base coverage. The unused commitment fee is 0.375% per year.
- Equity issuance: The company completed a sale of approximately 7,166,747 shares of common stock for aggregate consideration of $150.0 million on July 16, 2021.
Material Changes Versus the Prior Comparable Period
The filing does not provide prior-period financial statements or comparative operating results. The material changes disclosed are the establishment of the new $650 million revolving facility and the $150.0 million common-stock capital drawdown.
Guidance, Outlook, Risks, and Unusual Items
- Facility proceeds may be used for general corporate purposes, including funding portfolio investments.
- Borrowing capacity is subject to a borrowing base calculated using portfolio investments and other outstanding indebtedness.
- The company must make mandatory prepayments if a borrowing-base deficiency occurs. Additional mandatory prepayments apply after the commitment termination date from certain asset sales, recovery events, and equity or debt issuances.
- The facility contains covenants limiting additional indebtedness and certain distributions, share repurchases, and other acquisitions of shares upon specified events.
- Financial covenants address stockholders’ equity, net worth, asset coverage, liquidity, and other maintenance requirements. Customary events of default also apply.
- The equity issuance was made pursuant to subscription agreements requiring stockholders to fund drawdowns up to their capital commitments on an as-needed basis, with at least eight business days’ notice.
- The shares were issued without registration under Section 4(a)(2) of the Securities Act and Regulation D, based in part on investor representations that stockholders were accredited investors.
- The filing provides no earnings guidance, revenue outlook, profit figures, cash flow data, margin information, or current outstanding borrowings.
Investor Verification Checklist
- Verify the full credit agreement, including borrowing-base calculations, collateral exceptions, financial covenants, and events of default.
- Confirm the amount drawn and outstanding under the facility, as the filing states the maximum commitment but not actual borrowings.
- Review the company’s subsequent reports for compliance with asset-coverage, liquidity, net-worth, and other maintenance covenants.
- Confirm the use of the $150.0 million equity proceeds and the remaining uncalled capital commitments under the subscription agreements.
- Assess the effect of the facility’s secured leverage and mandatory prepayment provisions on portfolio-investment capacity and liquidity.